ClinicalTrials.gov
public full text
Public Domain
Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight
Photodynamic Therapy (PDT) is an effective treatment of basal cell carcinomas (BCC) however the inconvenience of clinic attendance and discomfort during therapy are significant drawbacks. The objective of this study is to evaluate the effect of daylight-mediated PDT of BCC.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Impact of donor substituents on photodynamic therapy performance: Comparative in vitro evaluation of NSeAze and NSeMorph in glioblastoma#200816
- Photodynamic Therapy for Prevention of Nonmelanoma Skin Cancer in Organ Transplant Recipients#1307541
- PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas#1228889
- From basic mechanisms to clinical research: photodynamic therapy applications in head and neck malignancies and vascular anomalies#781878
- Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer#230413
Record · ID 1195129
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive